SG Americas Securities LLC Has $647,000 Holdings in The Chemours Company $CC

SG Americas Securities LLC trimmed its stake in shares of The Chemours Company (NYSE:CC) by 81.4% during the third quarter, HoldingsChannel reports. The fund owned 40,843 shares of the specialty chemicals company’s stock after selling 178,733 shares during the period. SG Americas Securities LLC’s holdings in Chemours were worth $647,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in the stock. MTM Investment Management LLC bought a new position in Chemours during the 2nd quarter worth about $27,000. GAMMA Investing LLC grew its holdings in shares of Chemours by 130.7% during the second quarter. GAMMA Investing LLC now owns 3,175 shares of the specialty chemicals company’s stock worth $36,000 after buying an additional 1,799 shares in the last quarter. Evelyn Partners Asset Management Ltd acquired a new stake in Chemours in the 2nd quarter valued at approximately $37,000. FNY Investment Advisers LLC lifted its stake in Chemours by 100.0% in the 2nd quarter. FNY Investment Advisers LLC now owns 4,000 shares of the specialty chemicals company’s stock valued at $45,000 after acquiring an additional 2,000 shares in the last quarter. Finally, CWM LLC lifted its stake in Chemours by 34.7% in the 2nd quarter. CWM LLC now owns 4,290 shares of the specialty chemicals company’s stock valued at $49,000 after acquiring an additional 1,104 shares in the last quarter. 76.26% of the stock is owned by institutional investors.

Chemours Price Performance

Shares of CC opened at $16.06 on Friday. The company has a market cap of $2.41 billion, a price-to-earnings ratio of -7.23 and a beta of 1.61. The company has a current ratio of 1.71, a quick ratio of 0.88 and a debt-to-equity ratio of 13.66. The company’s fifty day simple moving average is $12.80 and its 200 day simple moving average is $13.77. The Chemours Company has a 1-year low of $9.13 and a 1-year high of $20.07.

Chemours (NYSE:CC) last announced its quarterly earnings data on Thursday, November 6th. The specialty chemicals company reported $0.20 EPS for the quarter, missing analysts’ consensus estimates of $0.24 by ($0.04). The firm had revenue of $1.50 billion during the quarter, compared to the consensus estimate of $1.50 billion. Chemours had a negative net margin of 5.70% and a positive return on equity of 35.27%. The business’s revenue was down .9% on a year-over-year basis. During the same period last year, the business earned $0.40 EPS. On average, research analysts forecast that The Chemours Company will post 2.03 earnings per share for the current fiscal year.

Chemours Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, December 15th. Shareholders of record on Friday, November 14th were given a dividend of $0.0875 per share. This represents a $0.35 dividend on an annualized basis and a yield of 2.2%. The ex-dividend date of this dividend was Friday, November 14th. Chemours’s payout ratio is -15.77%.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on CC shares. Royal Bank Of Canada reaffirmed an “outperform” rating and set a $18.00 price target on shares of Chemours in a research note on Friday, January 16th. BMO Capital Markets reaffirmed an “outperform” rating and issued a $20.00 target price on shares of Chemours in a research report on Monday. Truist Financial lifted their price target on shares of Chemours from $18.00 to $21.00 and gave the company a “buy” rating in a research note on Wednesday. UBS Group cut their price target on shares of Chemours from $21.00 to $18.00 and set a “buy” rating on the stock in a research report on Tuesday, November 11th. Finally, JPMorgan Chase & Co. decreased their price objective on Chemours from $15.00 to $13.00 and set a “neutral” rating for the company in a report on Wednesday, December 3rd. Five investment analysts have rated the stock with a Buy rating, four have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, Chemours currently has a consensus rating of “Hold” and an average price target of $16.67.

Chemours Profile

Chemours Company, established in 2015 as a spin-off from E. I. du Pont de Nemours and Company, is a global chemistry organization headquartered in Wilmington, Delaware. Since its formation, Chemours has focused on delivering performance chemicals that help customers lower their carbon footprint, increase energy efficiency and conserve water. The company operates with a commitment to safety, environmental stewardship and innovation.

Chemours’ principal business activities are organized into three core segments.